Status:
COMPLETED
Progestagens for the Tertiary Prophylaxis of Preterm Delivery
Lead Sponsor:
University of Modena and Reggio Emilia
Conditions:
Preterm Delivery
Neonatal Complications
Eligibility:
FEMALE
Phase:
PHASE3
Brief Summary
Objective: This trial would evaluate the clinical effectiveness of Progesterone(P) and 17-hydroxy Progesterone (17P) in reducing PTD, in symptomatic women at risk because of cervical shortening, in th...
Detailed Description
Background: According to the last reviews Progesterone (P) and (17P) are able to reduce preterm delivery (PTD), either as prophylactic administration in the presence of previous PTD or as a treatment ...
Eligibility Criteria
Inclusion
- Women with singleton pregnancy at 22+0nd to 31+6nd week of gestation presenting with a cervical length ≤25 mm, after an episode of preterm labour.
Exclusion
- Women with previous spontaneous PTD, multiple pregnancy, rupture of membranes, feto-maternal conditions indicating delivery, mullerian malformations, cervical surgery (cervical cerclage etc), presence of regular uterine contractions
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
254 Patients enrolled
Trial Details
Trial ID
NCT01178788
Start Date
February 1 2010
End Date
December 1 2015
Last Update
September 23 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Modena and Reggio Emilia
Modena, Italy, 41100